We are live on ! Find out more
ELOS

Syneron Medical Ltd
ELOS

Delisted

ELOS was delisted on the 14th of July, 2017.

Back to rankings

80 hedge funds and large institutions have $199M invested in Syneron Medical Ltd in 2016 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 32 increasing their positions, 9 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 4

256% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 9

23% more funds holding

Funds holding: 65 → 80 (+15)

22% more capital invested

Capital invested by funds: $163M → $199M (+$35.9M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

94% less call options, than puts

Call options by funds: $84K | Put options by funds: $1.39M

Holders
80
Holders Change
+15
Holders Change %
+23.08%
% of All Funds
2%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
20
Increased
32
Reduced
9
Closed
4
Calls
$84K
Puts
$1.39M
Net Calls
-$1.3M
Net Calls Change
-$1.21M

Top Buyers

Rank Fund Capital Flow
1
HP
HealthInvest Partners
Sweden
+$5.53M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$2.29M
3
KCP
Kenmare Capital Partners
New York
+$2.11M
4
BIP
Brandes Investment Partners
California
+$1.93M
5
DGHMC
Dalton, Greiner, Hartman, Maher & Co
New York
+$1.85M

Top Sellers

Rank Fund Capital Flow
1
RA
Royce & Associates
New York
-$2.75M
2
GIM
Granahan Investment Management
Massachusetts
-$1.31M
3
SM
Senvest Management
New York
-$513K
4
California Public Employees Retirement System
California Public Employees Retirement System
California
-$159K
5
Wolverine Trading
Wolverine Trading
Illinois
-$130K
Name Holding Trade Value Shares
Change 		Change in
Stake
GI
51
GAMCO Investors
Connecticut
$202K – – –
GCP
52
GSA Capital Partners
United Kingdom
$189K +$13K +1,654 +8%
SI
53
Sensato Investors
California
$178K +$166K +21,200 New
PP
54
PDT Partners
New York
$174K +$43.1K +5,500 +36%
RC
55
RBF Capital
California
$161K – – –
CCIA
56
Campbell & Co Investment Adviser
Maryland
$149K +$58.5K +7,468 +73%
VKH
57
Virtu KCG Holdings
New York
$136K +$127K +16,219 New
HCM
58
Hilton Capital Management
New York
$134K – – –
GF
59
Gabelli Funds
New York
$118K – – –
Walleye Trading
60
Walleye Trading
New York
$109K +$90.1K +11,500 +767%
TDC
61
Thompson Davis & Co
Virginia
$109K +$102K +13,000 New
Citadel Advisors
62
Citadel Advisors
Florida
$97K +$90.9K +11,592 New
Commonwealth Equity Services
63
Commonwealth Equity Services
Massachusetts
$84K -$4.75K -606 -6%
Group One Trading
64
Group One Trading
Illinois
$83K +$77.4K +9,870 New
TRCT
65
Tower Research Capital (TRC)
New York
$48K -$70.5K -8,998 -61%
JP Morgan Chase
66
JP Morgan Chase
New York
$47K -$54.3K -6,923 -56%
HIIFS
67
Harel Insurance Investments & Financial Services
Israel
$34K – – –
PCM
68
Penserra Capital Management
California
$33K -$5.74K -732 -15%
UBS Group
69
UBS Group
Switzerland
$18K +$15.1K +1,929 +772%
IA
70
IFP Advisors
Florida
$17K +$15.7K +2,000 New
Barclays
71
Barclays
United Kingdom
$14K -$6.53K -833 -33%
CG
72
Cutler Group
California
$10K – – –
BNP Paribas Financial Markets
73
BNP Paribas Financial Markets
France
$8.08K – – –
Wells Fargo
74
Wells Fargo
California
$6K +$1.08K +138 +23%
BlackRock
75
BlackRock
New York
$6K +$5.49K +700 New
1 2
3
4

ELOS Hedge Fund Activity: Q4 2016 in Review

80 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Syneron Medical Ltd (ELOS) for Q4 2016, worth a combined $199M — up 22% from $163M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new ELOS positions and 4 closed out — a net gain of 16 holders — while 32 added to existing stakes and 9 trimmed.

The largest buyer was HealthInvest Partners, opening a new position worth an estimated $5.53M. The largest seller was Royce & Associates, cutting an estimated $2.75M.

  • 80 institutional investors held Syneron Medical Ltd (ELOS) as of Q4 2016, up from 65 in Q3 2016.
  • Funds reported $199M of Syneron Medical Ltd stock for Q4 2016, up 22% quarter-over-quarter.
  • 20 funds opened new Syneron Medical Ltd positions in Q4 2016 and 4 closed out, a net change of +16 holders.
  • The largest Syneron Medical Ltd buyer in Q4 2016 was HealthInvest Partners, an estimated $5.53M added.
  • The largest Syneron Medical Ltd seller in Q4 2016 was Royce & Associates, an estimated $2.75M sold.

Based on aggregated 13F filings for Q4 2016.